FDA data Registry peer set 1 peer

Alternatives to plecanatide

1 same-class SPL records vs plecanatide - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Trulance

Guanylate Cyclase-C Agonist Prescription 1 alternative found

About plecanatide

Trulance is a medicine that helps adults with certain bowel problems. It helps your bowels move more regularly.

Used for: Trulance treats chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). CIC means you have ongoing constipation with no known cause. IBS-C means you have stomach pain and constipation.

1 Guanylate Cyclase-C Agonist peers (wide set)

Compare plecanatide vs linaclotide side-by-side →

plecanatide vs linaclotide · FAERS reaction fields

FAERS top-reaction field "Diarrhoea" shows the widest count spread between plecanatide and linaclotide in this extract (4,139-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect plecanatide linaclotide
Diarrhoea 363 4,502
Nausea 159 1,373
Constipation 152 1,862
Fatigue 106 1,111
Abdominal Distension 100 1,100
Abdominal Pain Upper 100 884
Abdominal Pain 96 1,009
Headache 96 982

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

plecanatide peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Guanylate Cyclase-C Agonist: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside plecanatide?
This registry lists 1 Guanylate Cyclase-C Agonist medication records beside plecanatide, including linaclotide. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Guanylate Cyclase-C Agonist peer set (1 records)

plecanatide (Trulance) sits in a wide Guanylate Cyclase-C Agonist peer set (1 of 1 class peers shown). Labeled indication field for plecanatide: Trulance treats chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).

Top FAERS reaction fields for plecanatide total 1,354 reports across 10 reactions, set beside linaclotide. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full plecanatide profile →

Field note for plecanatide: see also the generic vs brand label guide when reading Trulance SPL strings.